Tirzepatide has anecdotally been associated with reduced alcohol cravings in some users, but if a person with alcohol use disorder stops drinking suddenly while on bupropion, the withdrawal period combined with the lowered seizure threshold creates a genuinely dangerous situation
Video Endoscopic Sequence 2 of 8
Monitoring requirements Qsymia requires more routine monitoring than GLP-1 medications: Monthly pregnancy tests for women of childbearing age Regular heart rate monitoring Periodic blood work for bicarbonate levels (metabolic acidosis screening) Kidney function tests Mood and cognition assessment GLP-1 medications generally require less intensive monitoring, though periodic blood work to check pancreatic enzymes and kidney function is still recommended
Clinical data shows that most people regain approximately two-thirds of lost weight within 12 months of stopping GLP-1 therapy
[DOI] [PubMed] 52.Jeejeebhoy F., Keith M., Freeman M., Barr A., McCall M., Kurian R., Mazer D., Errett L
NAD : Nicotinamide adenine dinucleotide (NAD) is an important coenzyme that naturally decreases with age
